Literature DB >> 18432188

Common genetic variants in the chromogranin A promoter alter autonomic activity and blood pressure.

Y Chen1, F Rao, J L Rodriguez-Flores, N R Mahapatra, M Mahata, G Wen, R M Salem, P-A B Shih, M Das, N J Schork, M G Ziegler, B A Hamilton, S K Mahata, D T O'Connor.   

Abstract

Chromogranin A (CHGA) is stored and released from the same secretory vesicles that contain catecholamines in chromaffin cells and noradrenergic neurons. We had previously identified common genetic variants at the CHGA locus in several human populations. Here we focus on whether inter-individual variants in the promoter region are of physiological significance. A common haplotype, CGATA (Hap-B), blunted the blood pressure response to cold stress and the effect exhibited molecular heterosis with the greatest blood pressure change found in Hap-A/Hap-B heterozygotes. Homozygosity for three minor alleles with peak effects within the haplotype predicted lower stress-induced blood pressure changes. The G-462A variant predicted resting blood pressure in the population with higher pressures occurring in heterozygotes (heterosis). Using cells transfected with CHGA promoter-luciferase reporter constructs, the Hap-B haplotype had decreased luciferase expression compared to the TTGTC (Hap-A) haplotype under both basal conditions and after activation by pre-ganglionic stimuli. The G-462A variant altered a COUP-TF transcriptional control motif. The two alleles in transfected promoters differed in basal activity and in the responses to COUP-II-TF transactivation and to retinoic acid. In vitro findings of molecular heterosis were also noted with the transfected CHGA promoter wherein the diploid combination of the two G-462A alleles gave rise to higher luciferase expression than either allele in isolation. Our results suggest that common genetic variants in the CHGA promoter may regulate heritable changes in blood pressure.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18432188      PMCID: PMC2576285          DOI: 10.1038/ki.2008.113

Source DB:  PubMed          Journal:  Kidney Int        ISSN: 0085-2538            Impact factor:   10.612


  61 in total

Review 1.  COUP-TF orphan nuclear receptors in development and differentiation.

Authors:  F A Pereira; M J Tsai; S Y Tsai
Journal:  Cell Mol Life Sci       Date:  2000-09       Impact factor: 9.261

Review 2.  Physiological function of the orphans GCNF and COUP-TF.

Authors:  A J Cooney; C T Lee; S C Lin; S Y Tsai; M J Tsai
Journal:  Trends Endocrinol Metab       Date:  2001-08       Impact factor: 12.015

Review 3.  Heredity and the autonomic nervous system in human hypertension.

Authors:  D T O'Connor; P A Insel; M G Ziegler; V Y Hook; D W Smith; B A Hamilton; P W Taylor; R J Parmer
Journal:  Curr Hypertens Rep       Date:  2000-02       Impact factor: 5.369

Review 4.  Dissecting the genetic architecture of the cardiovascular and renal stress response.

Authors:  Harold Snieder; Gregory A Harshfield; Paule Barbeau; David M Pollock; Jennifer S Pollock; Frank A Treiber
Journal:  Biol Psychol       Date:  2002-10       Impact factor: 3.251

Review 5.  Cardiovascular reactivity and development of preclinical and clinical disease states.

Authors:  Frank A Treiber; Thomas Kamarck; Neil Schneiderman; David Sheffield; Gaston Kapuku; Teletia Taylor
Journal:  Psychosom Med       Date:  2003 Jan-Feb       Impact factor: 4.312

6.  Studies of the dysglycemic peptide, pancreastatin, using a human forearm model.

Authors:  Peter E Cadman; Fangwen Rao; Sushil K Mahata; Daniel T O'Connor
Journal:  Ann N Y Acad Sci       Date:  2002-10       Impact factor: 5.691

7.  Chromogranin A, an "on/off" switch controlling dense-core secretory granule biogenesis.

Authors:  T Kim; J H Tao-Cheng; L E Eiden; Y P Loh
Journal:  Cell       Date:  2001-08-24       Impact factor: 41.582

Review 8.  Molecular heterosis: a review.

Authors:  D E Comings; J P MacMurray
Journal:  Mol Genet Metab       Date:  2000 Sep-Oct       Impact factor: 4.797

9.  Early decline in the catecholamine release-inhibitory peptide catestatin in humans at genetic risk of hypertension.

Authors:  Daniel T O'Connor; Mala T Kailasam; Brian P Kennedy; Michael G Ziegler; Noboru Yanaihara; Robert J Parmer
Journal:  J Hypertens       Date:  2002-07       Impact factor: 4.844

10.  High-throughput development and characterization of a genomewide collection of gene-based single nucleotide polymorphism markers by chip-based matrix-assisted laser desorption/ionization time-of-flight mass spectrometry.

Authors:  K H Buetow; M Edmonson; R MacDonald; R Clifford; P Yip; J Kelley; D P Little; R Strausberg; H Koester; C R Cantor; A Braun
Journal:  Proc Natl Acad Sci U S A       Date:  2001-01-02       Impact factor: 11.205

View more
  18 in total

1.  Role of reactive oxygen species in hyperadrenergic hypertension: biochemical, physiological, and pharmacological evidence from targeted ablation of the chromogranin a (Chga) gene.

Authors:  Jiaur R Gayen; Kuixing Zhang; Satish P RamachandraRao; Manjula Mahata; Yuqing Chen; Hyung-Suk Kim; Robert K Naviaux; Kumar Sharma; Sushil K Mahata; Daniel T O'Connor
Journal:  Circ Cardiovasc Genet       Date:  2010-08-20

Review 2.  The extended granin family: structure, function, and biomedical implications.

Authors:  Alessandro Bartolomucci; Roberta Possenti; Sushil K Mahata; Reiner Fischer-Colbrie; Y Peng Loh; Stephen R J Salton
Journal:  Endocr Rev       Date:  2011-08-23       Impact factor: 19.871

3.  Conserved regulatory motifs at phenylethanolamine N-methyltransferase (PNMT) are disrupted by common functional genetic variation: an integrated computational/experimental approach.

Authors:  Juan L Rodríguez-Flores; Kuixing Zhang; Sun Woo Kang; Gen Wen; Sajalendu Ghosh; Ryan S Friese; Sushil K Mahata; Shankar Subramaniam; Bruce A Hamilton; Daniel T O'Connor
Journal:  Mamm Genome       Date:  2010-03-05       Impact factor: 2.957

4.  A haplotype variant of the human chromogranin A gene (CHGA) promoter increases CHGA expression and the risk for cardiometabolic disorders.

Authors:  Lakshmi Subramanian; Abrar A Khan; Prasanna K R Allu; Malapaka Kiranmayi; Bhavani S Sahu; Saurabh Sharma; Madhu Khullar; Ajit S Mullasari; Nitish R Mahapatra
Journal:  J Biol Chem       Date:  2017-06-30       Impact factor: 5.157

5.  Genome-wide case/control studies in hypertension: only the 'tip of the iceberg'.

Authors:  Kuixing Zhang; Alan B Weder; Eleazar Eskin; Daniel T O'Connor
Journal:  J Hypertens       Date:  2010-06       Impact factor: 4.844

6.  Genetic variation within a metabolic motif in the chromogranin a promoter: pleiotropic influence on cardiometabolic risk traits in twins.

Authors:  Fangwen Rao; Stephane Chiron; Zhiyun Wei; Maple M Fung; Yuqing Chen; Gen Wen; Srikrishna Khandrika; Michael G Ziegler; Beben Benyamin; Grant Montgomery; John B Whitfield; Nicholas G Martin; Jill Waalen; Bruce A Hamilton; Sushil K Mahata; Daniel T O'Connor
Journal:  Am J Hypertens       Date:  2011-09-15       Impact factor: 2.689

7.  Proteomic analysis yields an unexpected trans-acting point in control of the human sympathochromaffin phenotype.

Authors:  Stéphane Chiron; Zhiyun Wei; Yuqing Chen; Kuixing Zhang; Gen Wen; Wolfgang H Fischer; Sushil K Mahata; Daniel T O'Connor
Journal:  Circ Cardiovasc Genet       Date:  2011-05-06

8.  Long human CHGA flanking chromosome 14 sequence required for optimal BAC transgenic "rescue" of disease phenotypes in the mouse Chga knockout.

Authors:  Sucheta M Vaingankar; Ying Li; Angelo Corti; Nilima Biswas; Jiaur Gayen; Daniel T O'Connor; Sushil K Mahata
Journal:  Physiol Genomics       Date:  2009-12-15       Impact factor: 3.107

9.  Global metabolic consequences of the chromogranin A-null model of hypertension: transcriptomic detection, pathway identification, and experimental verification.

Authors:  Ryan S Friese; Jiaur R Gayen; Nitish R Mahapatra; Geert W Schmid-Schönbein; Daniel T O'Connor; Sushil K Mahata
Journal:  Physiol Genomics       Date:  2009-12-01       Impact factor: 3.107

Review 10.  Chromogranin A: a novel susceptibility gene for essential hypertension.

Authors:  Bhavani S Sahu; Parshuram J Sonawane; Nitish R Mahapatra
Journal:  Cell Mol Life Sci       Date:  2009-11-27       Impact factor: 9.261

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.